Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03510364
Other study ID # IRB2016-571
Secondary ID
Status Completed
Phase N/A
First received March 12, 2018
Last updated April 17, 2018
Start date June 2014
Est. completion date June 2015

Study information

Verified date April 2018
Source Texas Tech University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators examined the associations between SSS, energy balance, food intake and changes in body composition following a high calorie lunch for 2 weeks.


Description:

Subjective social status (SSS) is inversely associated with body fatness. The physiological and psychological effects of low social status may spur increased energy intake as a strategy to buffer against future food scarcity. Investigators' central hypothesis is that females with low SSS will not compensate for excess calorie consumption in a single large meal as well as individuals with high SSS, and will therefore remain in positive energy balance leading to body fat gain in response to daily large meals. Investigators' objective is to understand the influence of SSS on eating behavior, weight gain, and energetic compensation. Investigators conducted a 14-day feeding protocol that consisted of consumption of a lunch-time meal that was 60% of participants' estimated 24-hour energy requirements each day in female participants between 20-50 years, with a body mass index between 25- 30 kg/m2. Free-living food intake was recorded using the Remote Food Photography Method outside of the lab on days 1-2 (early), 7-8 (middle), and 12-13 (late), to measure compensation in response to the large lunch. 24-Hour energy balance, 24 hour intake and post-lunch energy intake were calculated for those days. Investigators measured body composition using Dual energy x ray absorptiometry (DXA), weight and resting energy expenditure at the baseline and at the end of the 14 days of the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- between 20-50 years

- body mass index between 25- 30 kg/m2

Exclusion Criteria:

- food allergies or food restrictions

- engaged in any weight reduction program within the past 3 months

- experienced any weight loss or gain of >5% of body weight in the past 6 months for any reason except post-partum weight loss

- taking any medication that suppresses or stimulates appetite

- undergone prior surgical procedures for weight control or liposuction

- current smoker or has not smoked in less than 6 months

- any major diseases including active cancer or cancer requiring treatment in the past 2 years (except non-melanoma skin cancer)

- active or chronic infections (e.g., HIV or TB)

- cardiovascular disease or event including hospitalization or therapeutic procedures for treatment of heart disease in the past 6 months

- gastrointestinal disease

- kidney disease

- chronic obstructive airway disease requiring use of oxygen (e.g., emphysema or chronic bronchitis)

- diabetes (type 1 or 2) and taking any anti-diabetic medications and/or controlling the disease via dietary manipulations

- uncontrolled psychiatric disease

- a recent or ongoing problem with drug abuse or addiction

- consume more than three alcoholic drinks per day and has had 7 or more alcoholic beverages in a 24 hour period in the last 12 months

- pregnant or less than 3 months post-partum

- currently nursing or within 6 weeks of having completed nursing

- anticipating a possible pregnancy during the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Dietary intervention
For the feeding intervention, participants consumed a meal that contains 60% of their energy daily energy requirement as a lunch time meal for 14 consecutive days under observation except during the weekends. To ensure the participant receives 60% of the daily energy requirement as a lunch meal we added a supplemental shake to the standard 1200 kcal meal.

Locations

Country Name City State
n/a

Sponsors (5)

Lead Sponsor Collaborator
Texas Tech University Indiana University, Pennington Biomedical Research Center, University of Alabama at Birmingham, University of Florida

Outcome

Type Measure Description Time frame Safety issue
Primary Average 24 hour energy balance (24hr EB) We measured 24-hr energy balance to assess the association of SSS with positive energy balance in response to a daily large meal perturbation. Twenty four hour energy balance was calculated for each time point as follows, and all six time points were averaged to get an average energy balance over the 2-week period:
24 hr Energy balance = Average 24 hr Energy intake / Resting Energy Expenditure *1.4 For the early and middle time point 24EB calculations, baseline resting energy expenditure (REE) was used and for late 24hr EB, final REE obtained at the end of the study was used.
Six time points ( Days 1, 2, 7, 8, 12 and 13) measured over the two week feeding protocol.
Secondary Average 24 hour energy intake (24hr EI) over a two week period Amount of total calories consumed over 24 hours. - consists of breakfast, morning snack, lunch, afternoon snack, dinner, evening snack within 24 hours. Average of six time points ( Days 1, 2, 7, 8, 12 and 13) over a two week period
Secondary Post-lunch energy intake Amount of total calories consumed after lunch - consists of afternoon snack, dinner, evening snack. Average of six time points (Days 1, 2, 7, 8, 12 and 13) over a two week period
Secondary Percent changes in body fat Changes in the body fat mass % change from baseline (day 0) to the end of the intervention period (day 14)
Secondary Percent changes in body weight Changes in the body weight % change from baseline (day 0) to the end of the intervention period (day 14)
Secondary Changes in adjusted resting energy expenditure Resting energy expenditure (REE) was adjusted to the lean mass. the change in adjusted REE = final adjusted REE - baseline adjusted REE change from baseline (day 0) to the end of the intervention period (day 14)
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2